News from NeuroVive Pharmaceutical AB A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Mar 22, 2013, 06:20 ET 600th Heart Attack Patient Recruited into Phase III CicloMulsion® CIRCUS Trial

NeuroVive, a leading mitochondrial medicine company, announces that the 600th patient has been recruited to a pivotal Phase III European,...


Mar 18, 2013, 06:06 ET NeuroVive Appoints Anna Malm Bernsten and Boel Flodgren to its Board of Directors

NeuroVive Pharmaceutical AB, a leading mitochondrial medicine company announces that Anna Malm Bernsten and Boel Flodgren have been elected to the...


Mar 11, 2013, 05:35 ET NeuroVive Acquires Highly Potent, Novel Cyclophilin Inhibitors From Biotica

NeuroVive, a leading mitochondrial medicine company, announces it has completed the acquisition of a portfolio of novel cyclophilin inhibitors,...


Dec 03, 2012, 04:35 ET NeuroVive Announces Publication of Phase I Clinical Trial of CicloMulsion® in Clinical Drug Investigation

NeuroVive announces publication of the results of a Phase I clinical trial of lead product CicloMulsion® in the scientific journal Clinical...


Apr 19, 2011, 07:00 ET First Heart Attack Patient Treated in European Cardioprotection Phase III trial with NeuroVive's CicloMulsion(TM)

Investigator-initiated European multicenter trial of 1,000 acute heart attack patients will examine the ability of cyclosporine to protect...